Biotech / Pharma
Typewriter
Biotech / Pharma
Typewriter, a Cambridge/Tokyo biotech company, raised a $56M Series A led by AN Venture Partners and RA Capital for RNA-based in-vivo CAR-T gene-editing therapy.
Founded
Region
Investors
People